Get Naltrexone

Get Naltrexonehttps://getnaltrexone.com/2026-10-22T14:16:28.998ZGet NaltrexoneNaltrexone Contraindications: Opioids, Withdrawal, and Label Checkshttps://getnaltrexone.com/blog/naltrexone-contraindications/2026-08-26T00:00:00.000Z

Understand the current US-label contraindications for oral naltrexone and Vivitrol, and why recent opioid exposure needs a clinician review.

Starting Naltrexone After Opioids: Why the Opioid-Free Interval Mattershttps://getnaltrexone.com/blog/naltrexone-opioid-free-initiation/2026-08-26T00:00:00.000Z

Why naltrexone requires a clinician-confirmed opioid-free interval, what the 7–10-day minimum means, and the role and limits of naloxone challenge testing.

Naltrexone Side Effects: Expected Effects and Urgent Safety Signalshttps://getnaltrexone.com/blog/naltrexone-side-effects-and-safety/2026-08-26T00:00:00.000Z

Common naltrexone side effects, Vivitrol injection-site reactions, and urgent symptoms described in current US product labels.

Vivitrol Injection Administration: What Patients Should Knowhttps://getnaltrexone.com/blog/vivitrol-injection-administration/2026-08-26T00:00:00.000Z

Vivitrol is a healthcare-provider-only deep gluteal injection. Learn the labelled frequency, patient role, and injection-site safety warnings.

Australia Naltrexone PBS Check: Item 8370M and 2026 Co-paymentshttps://getnaltrexone.com/blog/naltrexone-australia-pbs-guide/2026-08-26T00:00:00.000Z

A dated check of Australian PBS item 8370M, 2026 maximum co-payments, and the other treatment costs to verify.

Naltrexone and Liver Disease: What Current Evidence Showshttps://getnaltrexone.com/blog/naltrexone-liver-health-hepatotoxicity/2026-08-26T00:00:00.000Z

A careful review of naltrexone liver-safety evidence, including observational cirrhosis studies, label warnings, and remaining uncertainty.

New Zealand Naltrexone Funding: June 2026 PHARMAC Checkhttps://getnaltrexone.com/blog/naltrexone-nz-pharmac-funding/2026-10-22T00:00:00.000Z

June 2026 PHARMAC evidence for Naltraccord funding, Special Authority SA1408, pharmacy charges, and GP fees.

Naltrexone During Pregnancy and Breastfeeding: What We Knowhttps://getnaltrexone.com/blog/naltrexone-pregnancy-breastfeeding/2026-08-26T00:00:00.000Z

What current labels and LactMed say about naltrexone during pregnancy and breastfeeding, including the limits of human evidence.

Singapore Naltrexone Check: Contrave Is Registered—What About 50 mg?https://getnaltrexone.com/blog/naltrexone-singapore-access/2026-08-26T00:00:00.000Z

A July 2026 check of Singapore's official formulary, Contrave licence SIN16411P, and the limits of evidence for standalone naltrexone.

UAE Naltrexone Registry Check: What Is Actually Listed?https://getnaltrexone.com/blog/naltrexone-uae-cost-clinics/2026-08-26T00:00:00.000Z

A July 2026 evidence check of UAE registration for standalone naltrexone, Trexan, Contrave, and Mysimba.

Naltrexone vs Acamprosate and Disulfiramhttps://getnaltrexone.com/blog/naltrexone-vs-other-medications/2026-08-26T00:00:00.000Z

Compare naltrexone, acamprosate, and disulfiram for alcohol use disorder: treatment goals, dosing, liver and kidney considerations, and evidence.

Does Naltrexone Help With Weight Loss? Contrave Evidencehttps://getnaltrexone.com/blog/naltrexone-weight-loss-contrave-evidence/2026-08-26T00:00:00.000Z

Does naltrexone help with weight loss? Evidence on the approved naltrexone-bupropion combination, Contrave: eligibility, trial results, safety, and limits.

Targeted Naltrexone in Asia-Pacific: What Access Evidence Showshttps://getnaltrexone.com/blog/sinclair-method-asia-pacific/2026-10-22T00:00:00.000Z

A country evidence check for targeted naltrexone in Australia, New Zealand, Singapore, and the UAE.